Biotech Stocks Get Traction But Still Lag Broader Market…Update-2…Rally Mode
Update-2... Broad Tradable Rally Continues 12:30 PM EST XBI leads IBB today up 4.2% vs 2.9%. XBI at $54 is now up 9.55% over 5 days and well off Feb. 11 bottom of $44. This is a broad rally today with most biotech stocks up and the most speculative stocks are big movers. Check your holdings...
Can El Nino Finally Save the West Coast Winter? Yes!
Update-1... 3/4/16 20-40 inches this weekend: Mammoth Mountain Snowman Report ------- Breakdown of High Pressure Ridge Will Bring Storms Next Week Over the past two weeks El Nino has gotten no respect despite assurances from NOAA forecasters that El Nino is still in effect and predicted...
Crude Stabilizes then Biotech Turns Green: Stay Tuned But Cautious
Biotech Stocks Off Lows Tracking Crude and Energy sector... 11.45 a EST Can healthcare stocks uncouple from energy and macro? Individual biotech stocks look very tradable with green catching up with red. But biotech stocks defy fundamental analysis with current random hourly volatility. IBB...
Biotech Stocks Lag Today’s Rally: S&P 500 Erases February Losses But Still Down 4.4% YTD…Update-1
2/23 After Close---Energy Rout Burns Biotech Stocks and NASDAQ The red screen dominated except few winners like ZIOPHARM Oncology (ZIOP) up 13.95% on a publication regarding gene editing. Another gene editing stock and recent IPO Editas Medicine (EDIT) was up 4.63% to $22.62. Large cap...
Large Cap Biopharma Winners and Losers 2015-16: Which Stocks Can Beat the ETFs?… Part 2
Rayno Large Cap Biopharmaceuticals...Part 2...A Stock pickers Market Time to Rebuild Your Portfolio: ABBV, BMY, GILD Below we have summarized selective metrics for large cap biopharmaceutical companies. We began the process of revising and rebalancing our portfolio after the J.P.Morgan...